The cost of remdesivir for a 5-day course of treatment is $2,340 in all developed countries, a price tag that is similar to cost-effectiveness estimates previously shared by a drug-pricing watchdog organization. There is one exception, however; in the U.S., the cost for a patient who has commercial health insurance, including a plan through their employer and purchased on the health exchanges, is $3,120.
www.marketwatch.com
lol lol lol Wasn't this stuff supposed to cost around $2 a dose just a couple weeks ago?
![www.marketwatch.com](https://s.marketwatch.com/public/resources/images/MW-IE301_remdes_ZG_20200413134610.jpg)
Gileadâs coronavirus drug will cost $2,340 â which sounds expensive, but hereâs why itâs not
Gilead Sciences Inc.’s COVID-19 drug remdesivir will cost much less than Wall Street analysts had predicted in a move that likely points to a more measured,...
![www.marketwatch.com](https://mw4.wsj.net/mw5/content/images/favicons/apple-touch-icon.png)
lol lol lol Wasn't this stuff supposed to cost around $2 a dose just a couple weeks ago?